Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - OPIANT PHARMACEUTICALS, INC. | opnt12312019exhibit322.htm |
| EX-32.1 - EXHIBIT 32.1 - OPIANT PHARMACEUTICALS, INC. | opnt12312019exhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - OPIANT PHARMACEUTICALS, INC. | opnt12312019exhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - OPIANT PHARMACEUTICALS, INC. | opnt12312019exhibit311.htm |
| EX-4.2 - EXHIBIT 4.2 - OPIANT PHARMACEUTICALS, INC. | exhibit42.htm |
| 10-K - 10-K - OPIANT PHARMACEUTICALS, INC. | opnt1231201910-k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on Form S-3 (File No. 333-220976) and Form- S-8 (File Nos. 333-221759 and 333-224239) of our report dated March 4, 2020 with respect to the audited consolidated financial statements of Opiant Pharmaceuticals, Inc. included in the Annual Report on Form 10 K for the year ended December 31, 2019.
/s/ MaloneBailey, LLP www.malonebailey.com
Houston, Texas
March 4, 2020